These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 1945284)

  • 21. Daunorubicin treatment in a refined experimental model of proliferative vitreoretinopathy.
    Khawly JA; Saloupis P; Hatchell DL; Machemer R
    Graefes Arch Clin Exp Ophthalmol; 1991; 229(5):464-7. PubMed ID: 1937080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improvement in efficacy of corticosteroid therapy in an animal model of proliferative vitreoretinopathy by pretreatment.
    Chandler DB; Hida T; Sheta S; Proia AD; Machemer R
    Graefes Arch Clin Exp Ophthalmol; 1987; 225(4):259-65. PubMed ID: 3653718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiproliferative effect of retinoic acid in intravitreous silicone oil in an animal model of proliferative vitreoretinopathy.
    Araiz JJ; Refojo MF; Arroyo MH; Leong FL; Albert DM; Tolentino FI
    Invest Ophthalmol Vis Sci; 1993 Mar; 34(3):522-30. PubMed ID: 8449673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proliferative vitreo-retinal disorders: experimental models in vivo and in vitro.
    Martini B
    Acta Ophthalmol Suppl (1985); 1992; (201):1-63. PubMed ID: 1322004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Taxol treatment of experimental proliferative vitreoretinopathy.
    Daniels SA; Coonley KG; Yoshizumi MO
    Graefes Arch Clin Exp Ophthalmol; 1990; 228(6):513-6. PubMed ID: 1979953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N,N-dimethyladriamycin for treatment of experimental proliferative vitreoretinopathy: efficacy and toxicity on the rabbit retina.
    Steinhorst UH; Chen EP; Machemer R; Hatchell DL
    Exp Eye Res; 1993 Apr; 56(4):489-95. PubMed ID: 8500561
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evaluation of experimental proliferative vitreoretinopathy in rabbits].
    Kuriyama S; Ohuchi T; Okada M; Yamakawa R; Yoshimura N; Honda Y
    Nippon Ganka Gakkai Zasshi; 1990 Sep; 94(9):792-8. PubMed ID: 2248164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of experimental intraocular proliferation with intravitreal 5-fluouracil.
    Binder S; Riss B; Skorpik C; Kulnig W
    Graefes Arch Clin Exp Ophthalmol; 1983; 221(3):126-9. PubMed ID: 6667861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of combined daunorubicin and triamcinolone acetonide treatment on a refined experimental model of proliferative vitreoretinopathy.
    Chen EP; Steinhorst UH; Samsa GP; Saloupis PT; Hatchell DL
    Invest Ophthalmol Vis Sci; 1992 Jun; 33(7):2160-4. PubMed ID: 1607226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liposome suppression of proliferative vitreoretinopathy. Rabbit model using antimetabolite encapsulated liposomes.
    Assil KK; Hartzer M; Weinreb RN; Nehorayan M; Ward T; Blumenkranz M
    Invest Ophthalmol Vis Sci; 1991 Oct; 32(11):2891-7. PubMed ID: 1917392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Early posterior capsule fibrosis after combined cataract and vitreoretinal surgery with intraocular air/SF6 gas tamponade].
    Scharwey K; Pavlovic S; Jacobi KW
    Klin Monbl Augenheilkd; 1998 Mar; 212(3):149-53. PubMed ID: 9592739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An intravitreal biodegradable sustained release naproxen and 5-fluorouracil system for the treatment of experimental post-traumatic proliferative vitreoretinopathy.
    Cardillo JA; Farah ME; Mitre J; Morales PH; Costa RA; Melo LA; Kuppermann B; Jorge R; Ashton P
    Br J Ophthalmol; 2004 Sep; 88(9):1201-5. PubMed ID: 15317716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preretinal membrane formation in rabbit eyes after intravitreal transplantation of cultured astrocytes.
    Mishima N; Yamashita H; Ishii Y; Hori S
    Jpn J Ophthalmol; 1989; 33(4):501-18. PubMed ID: 2696800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Models for assessing scar tissue inhibitors.
    van Bockxmeer FM; Martin CE; Constable IJ
    Retina; 1985; 5(1):47-60. PubMed ID: 4001590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of experimental intraocular proliferation with intravitreous 5-fluouracil. A transmission electron-microscopic study in rabbits.
    Kulnig W; Binder S; Riss B; Skorpik C
    Ophthalmologica; 1984; 188(4):248-58. PubMed ID: 6739043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperthermia reduces the occurrence of proliferative vitreoretinopathy in a rabbit model.
    Yoshimura N; Kuriyama S; Ohuchi T; Takemura M; Honda Y; Hiraoka M
    Invest Ophthalmol Vis Sci; 1992 Feb; 33(2):404-9. PubMed ID: 1740372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Models for assessing scar tissue inhibitors.
    van Bockxmeer FM; Martin CE; Constable IJ
    Retina; 1985; 5(4):239-52. PubMed ID: 3835621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fellow eye findings of highly myopic subjects operated for retinal detachment associated with a macular hole.
    Ripandelli G; Coppé AM; Parisi V; Stirpe M
    Ophthalmology; 2008 Sep; 115(9):1489-93. PubMed ID: 18439680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative assessment of growth stimulating activity of the vitreous during PVR.
    Yang CM; Cousins SW
    Invest Ophthalmol Vis Sci; 1992 Jul; 33(8):2436-42. PubMed ID: 1634341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of posterior vitreous detachment in rabbits by intravitreal injection of tissue plasminogen activator following cryopexy.
    Hesse L; Nebeling B; Schroeder B; Heller G; Kroll P
    Exp Eye Res; 2000 Jan; 70(1):31-9. PubMed ID: 10644418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.